These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23573554)

  • 21. [Oxaliplatin in colorectal carcinoma: from palliation to cure].
    Arnheim K
    Onkologie; 2004 Aug; 27 Suppl 1():2-11. PubMed ID: 23570154
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxaliplatin: results in colorectal carcinoma.
    Carrato A; Gallego J; Díaz-Rubio E
    Crit Rev Oncol Hematol; 2002 Oct; 44(1):29-44. PubMed ID: 12398998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin-induced immune thrombocytopenia.
    Pavic M; Moncharmont P; Sève P; Rigal D; Broussolle C
    Gastroenterol Clin Biol; 2006 May; 30(5):797-8. PubMed ID: 16801909
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent data with oxaliplatin-containing regimens in the adjuvant treatment of colorectal cancer.
    Reddy GK
    Clin Colorectal Cancer; 2005 Jul; 5(2):83-5. PubMed ID: 16098247
    [No Abstract]   [Full Text] [Related]  

  • 25. Perspectives in colorectal cancer meeting. Miami, Florida. September 28-29, 2001.
    Maung K; Fisher MD
    Clin Colorectal Cancer; 2001 Nov; 1(3):140-5. PubMed ID: 12450425
    [No Abstract]   [Full Text] [Related]  

  • 26. Roles of infusional high-dose 5-fluorouracil with leucovorin in advanced colorectal cancer.
    Liu JH
    Clin Colorectal Cancer; 2004 Sep; 4(3):204-5. PubMed ID: 15377404
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple liver lesions after oxaliplatin-based chemotherapy for colorectal cancer.
    Shlomai A; Tobar A; Benjaminov O
    Gastroenterology; 2015 Nov; 149(6):e1-3. PubMed ID: 26433107
    [No Abstract]   [Full Text] [Related]  

  • 28. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
    Mayer RJ
    J Clin Oncol; 2007 Sep; 25(27):4165-7. PubMed ID: 17709796
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 30. Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial.
    Chong G; Cunningham D
    Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):79-80. PubMed ID: 15830568
    [No Abstract]   [Full Text] [Related]  

  • 31. Second-line therapy in colorectal cancer.
    Berlin J
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):21-6. PubMed ID: 11204658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer.
    Simpson D; Dunn C; Curran M; Goa KL
    Drugs; 2003; 63(19):2127-56. PubMed ID: 12962525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tolerability of Oxaliplatin-Based Adjuvant Chemotherapy for Patients with Colorectal Cancer].
    Matsuo H; Nakanishi M; Arita T; Murayama Y; Kuriu Y; Kosuga T; Konishi H; Morimura R; Komatsu S; Shiozaki A; Ikoma H; Ichikawa D; Fujiwara H; Okamoto K; Otsuji E
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2112-4. PubMed ID: 26805281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer.
    Hejna M; Köstler WJ; Raderer M; Tomek S; Brodowicz T; Scheithauer W; Wiltschke C; Zielinski CC
    Anticancer Drugs; 2000 Sep; 11(8):629-34. PubMed ID: 11081454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxaliplatin: a new therapeutic option in colorectal cancer.
    Cvitkovic E; Bekradda M
    Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged survival of patients with metastatic colorectal cancer following first-line oxaliplatin-based chemotherapy with molecular targeting agents and curative surgery.
    Shitara K; Matsuo K; Kondo C; Takahari D; Ura T; Inaba Y; Yamaura H; Sato Y; Kato M; Kanemitsu Y; Komori K; Ishiguro S; Sano T; Shimizu Y; Muro K
    Oncology; 2011; 81(3-4):167-74. PubMed ID: 22057124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxaliplatin with 5-FU or as a single agent in advanced/metastatic colorectal cancer.
    Mitchell EP
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):30-2. PubMed ID: 11204660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-1 with leucovorin and oxaliplatin for advanced gastric cancer.
    Ter Veer E; van Oijen MGH; van Laarhoven HWM
    Lancet Oncol; 2016 Feb; 17(2):e41. PubMed ID: 26868348
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxaliplatin for colorectal cancer in the United States: better late than never.
    Chau I; Cunningham D
    J Clin Oncol; 2003 Jun; 21(11):2049-51. PubMed ID: 12775727
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts.
    Sawada N; Kondoh K; Mori K
    Oncol Rep; 2007 Oct; 18(4):775-8. PubMed ID: 17786335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.